Christopher N. Scanlan

6.3k citations

31 papers · 4.4k indexed · 3 hit papers · h-index 24

Impact in

Virology top 0.2%
- HIV Research and Treatment
Immunology top 2%
- Immune Cell Function and Interaction
- Galectins and Cancer Biology

Papers in

Virology 11
- HIV Research and Treatment 11
Radiology, Nuclear Medicine and Imaging 15
- Monoclonal and Polyclonal Antibodies Research 15

Co-authors: Raymond A. Dwek Dennis R. Burton Max Crispin Ian A. Wilson Nicole Zitzmann Mark R. Wormald Pauline M. Rudd D.A. Calarese
Journals: Journal of Molecular Biology (4 papers)Journal of the American Chemical Society (3 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of the American Society for Mass Spectrometry (2 papers)Journal of Virology (2 papers)
Partner nations: United Kingdom United States Belgium

In The Last Decade

Christopher N. Scanlan

31 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins 2004 · 905 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Proceedings of the National Academy of Sciences
2003 Science
2002 Journal of Virology

Peers

Countries citing papers authored by Christopher N. Scanlan

Since Specialization

Citations

This map shows the geographic impact of Christopher N. Scanlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher N. Scanlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher N. Scanlan more than expected).

Fields of papers citing papers by Christopher N. Scanlan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher N. Scanlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher N. Scanlan. The network helps show where Christopher N. Scanlan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher N. Scanlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher N. Scanlan Line = papers co-authored together Christopher N. Scanlan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor Molecular Immunology ·Snežana Vasiljević, Илья Олегович Бойко, Camille Bonomelli, Luisa Fernanda Acuña-Puello, Laura K. Pritchard, Gemma E. Seabright, Alessandro T. Caputo, Christopher N. Scanlan, Martin Dalziel, Max Crispin	2015	3
2	Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies Nature Communications ·Laura K. Pritchard, Daniel I. R. Spencer, Louise Royle, Camille Bonomelli, Gemma E. Seabright, Anna‐Janina Behrens, Daniel W. Kulp, Sergey Menis, Stefanie A. Krumm, D. Cameron Dunlop, A Aliahmadi, Thomas A. Bowden, Christopher N. Scanlan, Andrew B. Ward, William R. Schief, Katie J. Doores, Max Crispin	2015	96
3	Emerging Principles for the Therapeutic Exploitation of Glycosylation Science ·Martin Dalziel, Max Crispin, Christopher N. Scanlan, Nicole Zitzmann, Raymond A. Dwek	2014	369
4	Fragments of Bacterial Endoglycosidase S and Immunoglobulin G Reveal Subdomains of Each That Contribute to Deglycosylation Journal of Biological Chemistry ·Josef Steinegger, Natália Bravim Rinco, David J. Harvey, Kavitha Baruah, Xiaojie Yu, 王書輝, Ricardo Pandiangan, Laura K. Pritchard, Benjamin A. Krishna, Christopher N. Scanlan, Jason R. Schnell, Matthew K. Higgins, Nicole Zitzmann, Max Crispin	2014	23
5	Dissecting the Molecular Mechanism of IVIg Therapy: The Interaction between Serum IgG and DC-SIGN is Independent of Antibody Glycoform or Fc Domain Journal of Molecular Biology ·Xiaojie Yu, Snežana Vasiljević, Daniel A. Mitchell, Max Crispin, Christopher N. Scanlan	2013	102
6	Engineering Hydrophobic Protein–Carbohydrate Interactions to Fine-Tune Monoclonal Antibodies Journal of the American Chemical Society ·Xiaojie Yu, Kavitha Baruah, David J. Harvey, Snežana Vasiljević, Dominic S. Alonzi, Ree Bebetu, Matthew K. Higgins, Thomas A. Bowden, Christopher N. Scanlan, Max Crispin	2013	75
7	Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions Journal of Molecular Biology ·Kavitha Baruah, Thomas A. Bowden, Benjamin A. Krishna, Raymond A. Dwek, Max Crispin, Christopher N. Scanlan	2012	49
8	Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cells Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Chao Yu, Max Crispin, Andreas F.‐P. Sonnen, David J. Harvey, Veronica T. Chang, Edward J. Evans, Christopher N. Scanlan, David I. Stuart, Robert J.C. Gilbert, Simon J. Davis	2011	17
9	The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade PLoS ONE ·Camille Bonomelli, Katie J. Doores, D. Cameron Dunlop, Louise Herbreteau, Raymond A. Dwek, Dennis R. Burton, Max Crispin, Christopher N. Scanlan	2011	180
10	Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens Proceedings of the National Academy of Sciences ·Katie J. Doores, Camille Bonomelli, David J. Harvey, Snežana Vasiljević, Raymond A. Dwek, Dennis R. Burton, Max Crispin, Christopher N. Scanlan	2010	263
11	Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity Journal of Molecular Biology ·Leopold Kong, Neil C. Sheppard, Guillaume B. E. Stewart-Jones, Bita Shahrami, Hongying Chen, Xiaodong Xu, George Krashias, Camille Bonomelli, Christopher N. Scanlan, Peter D. Kwong, S. A. Jeffs, Ian M. Jones, Quentin J. Sattentau	2010	60
12	Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans Glycobiology ·D. Cameron Dunlop, Camille Bonomelli, Thomas Leigh Blundell, Snežana Vasiljević, Katie J. Doores, Mark R. Wormald, Angelina S. Palma, Ten Feizi, David J. Harvey, Raymond A. Dwek, Max Crispin, Christopher N. Scanlan	2010	60
13	Antigenic mimicry of the HIV envelope by AIDS-associated pathogens AIDS ·D. Cameron Dunlop, Alexander Ulrich, Ben J. Appelmelk, Dennis R. Burton, Raymond A. Dwek, Nicole Zitzmann, Christopher N. Scanlan	2008	22
14	Application of through mold via (TMV) as PoP base package Pokam Njoko R., Kiwook Lee, Viktor Krchnˇák, MARIANA DEPOLLO DALBEN, Kwangho Kim, A. Syvanen, Jae-Dong Kim, 恵水田, Christopher N. Scanlan, Koós Bálint György, Curtis Zwenger, Lee Smith, Kamble B. Venkatrao, Robert Darveaux	2008	35
15	Inhibition of Mammalian Glycan Biosynthesis Produces Non-self Antigens for a Broadly Neutralising, HIV-1 Specific Antibody Journal of Molecular Biology ·Christopher N. Scanlan, Nimra Fazil, Kavitha Baruah, Max Crispin, David J. Harvey, Bernhard B. Singer, Lothar Lucka, Mark R. Wormald, Paul Wentworth, Nicole Zitzmann, Pauline M. Rudd, Dennis R. Burton, Raymond A. Dwek	2007	56
16	Exploiting the defensive sugars of HIV-1 for drug and vaccine design Nature ·Christopher N. Scanlan, John Offer, Nicole Zitzmann, Raymond A. Dwek	2007	204
17	Printed covalent glycan array for ligand profiling of diverse glycan binding proteins Proceedings of the National Academy of Sciences ·Ola Blixt, Steve Head, Tony S. Mondala, Christopher N. Scanlan, Margaret E. Huflejt, Richard Alvarez, Marian C. Bryan, Fabio Fazio, D.A. Calarese, James Stevens, Nahid Razi, David Stevens, J.J. Skehel, Irma van Die, Dennis R. Burton, Ian A. Wilson, Richard D. Cummings, Nicolai V. Bovin, Chi‐Huey Wong, James C. Paulson Hit paper breakdown →	2004	905
18	Reactivity‐Based One‐Pot Synthesis of Oligomannoses: Defining Antigens Recognized by 2G12, a Broadly Neutralizing Anti‐HIV‐1 Antibody Angewandte Chemie International Edition ·Hing‐Ken Lee, Christopher N. Scanlan, Cheng‐Yuan Huang, Aileen Y. Chang, D.A. Calarese, Raymond A. Dwek, Pauline M. Rudd, Dennis R. Burton, Ian A. Wilson, Chi‐Huey Wong	2004	99
19	Reactivity‐Based One‐Pot Synthesis of Oligomannoses: Defining Antigens Recognized by 2G12, a Broadly Neutralizing Anti‐HIV‐1 Antibody Angewandte Chemie ·Hing‐Ken Lee, Christopher N. Scanlan, Cheng‐Yuan Huang, Aileen Y. Chang, D.A. Calarese, Raymond A. Dwek, Pauline M. Rudd, Dennis R. Burton, Ian A. Wilson, Chi‐Huey Wong	2004	14
20	Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition Science ·D.A. Calarese, Christopher N. Scanlan, Michael B. Zwick, Songpon Deechongkit, Yusuke Mimura, Renate Kunert, Ping Zhu, Mark R. Wormald, Robyn L. Stanfield, Kenneth H. Roux, Jeffery W. Kelly, Pauline M. Rudd, Raymond A. Dwek, Hermann Katinger, Dennis R. Burton, Ian A. Wilson Hit paper breakdown →	2003	632

About Christopher N. Scanlan

Christopher N. Scanlan is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry, Molecular Biology and Spectroscopy, having authored 31 papers that have together received 4.4k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (28 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Carbohydrate Chemistry and Synthesis (15 papers), HIV Research and Treatment (11 papers), Galectins and Cancer Biology (5 papers), Mass Spectrometry Techniques and Applications (4 papers), Chemical Synthesis and Analysis (2 papers) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Virology (1.6k citations), Immunology (1.3k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations), Molecular Biology (3.1k citations) and Organic Chemistry (1.3k citations). Christopher N. Scanlan has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Raymond A. Dwek, Dennis R. Burton, Max Crispin, Ian A. Wilson, Nicole Zitzmann, Mark R. Wormald, Pauline M. Rudd, D.A. Calarese, Robyn L. Stanfield and Hermann Katinger. Their work appears in journals such as Journal of Molecular Biology, Journal of the American Chemical Society, Proceedings of the National Academy of Sciences, Journal of the American Society for Mass Spectrometry and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact